++++which BP will be next to ante up in this indication? What about SGP, PFE and GSK?
And who will try to ante up to try to partner/collab the novel and first in class antiviral compound in trials right now known as Bavituximab???
That mAB has as good or better chance of eradicating and leaving the virus as non mutatable as any Protease inhibitor or even IDIX's drug in trial now.
Without sounding biased as a PPHM longtime shareholder who would not be, without the Bavi AC/AV programs in clinical trials, the unique MOA of Bavi AV will be an entirely different approach to this scourge that disables, debilitates, kills millions yearly along with the socioeconomic toll and relational toll that it takes on families, friends and at the workplace....
Market Data 
Markets 
AI
